No shared counterparties.
| Stage | ALSN | % of rev | MSM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $1.1B | 100.00% | ALSN ×1.45 |
| Gross profit | $515M | 32.89% | $439M | 40.64% | MSM +7.8pp |
| Operating income | $291M | 18.58% | $73M | 6.75% | ALSN +11.8pp |
| Pre-tax income | $228M | 14.56% | $64M | 5.96% | ALSN +8.6pp |
| Net income | $181M | 11.56% | $48M | 4.44% | ALSN +7.1pp |
| Stage | ALSN | MSM | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $1.1B100.00% | ALSN ×1.45 |
| Gross profit | 32.89%$515M | 40.64%$439M | MSM +7.8pp |
| Operating income | 18.58%$291M | 6.75%$73M | ALSN +11.8pp |
| Pre-tax income | 14.56%$228M | 5.96%$64M | ALSN +8.6pp |
| Net income | 11.56%$181M | 4.44%$48M | ALSN +7.1pp |